Spiriva

Spiriva

(spə-rē′və)
A trademark for the drug tiotropium bromide.

Spiriva

A long-acting once-daily antimuscarinic bronchodilator indicated for long-term management of bronchospasm in chronic obstructive pulmonary disease (COPD) (e.g., chronic bronchitis, emphysema).

Adverse effects
Dry mouth, constipation, vomiting, dyspepsia.

Spiriva

A brand name for TIOTROPIUM BROMIDE.
References in periodicals archive ?
Christian Boehringer, Chairman of the Shareholders' Committee says: 'Innovative medicines like SPIRIVA and OFEV for respiratory as well as JARDIANCE and TRAJENTA in diabetes have substantially improved therapy options for patients.
Previously, he held a number of senior posts at Pfizer, and oversaw the UK launch of Spiriva under the company's copromotion agreement with Boehringer Ingelheim.
Asthma drug Spiriva costs nearly six times as much, with an estimated US cost of PS194.30 per 30 capsules, compared to PS33.50 in the UK.
Asthma drug Spiriva costs nearly six times as much and Neulasta, which fights infection during chemotherapy, is nearly three-and-a-half times dearer.
This phase III clinical trial compared the efficacy and safety of inhaled DUAKLIR PRESSAIR to its individual components aclidinium and formoterol, and to inhaled Spiriva Handihaler (tiotropium) in 1,583 patients with moderate-to-very-severe symptomatic.
Clinical review report: tiotropium bromide monohydrate (Spiriva Respimat) for oral inhalation for the long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, and for the reduction of exacerbations [Internet].
According to the company, the new labeling for Stiolto Respimat Inhalation Spray includes data showing a meaningful reduction in COPD exacerbations driven by tiotropium, which is the active ingredient in Spiriva Respimat (tiotropium bromide) Inhalation Spray.
Those six include long-acting sedative hypnotics, including diazepam (Valium); loop diuretics; and anticholinergic agents, including sedating antihistamines, antipsychotics, tricyclic antidepressants, and tiotropium bromide (Spiriva).
PUR0200 is a once-daily, reformulation of tiotropium bromide for COPD patients and is being developed as a branded alternative to Spiriva HandiHaler.
Geographies covered: US Germany France Italy Spain UK Japan Australia Canada Drugs covered Spiriva Tudorza Pressair Seebri Neohaler Incruse Ellipta Arcapta Neohaler/Onbrez Striverdi Respimat Advair/Seretide Symbicort Turbuhaler Breo Ellipta Ultibro/Utibron Anoro Ellipta Brimica Genuair/Duaklir Stiolto Respimat Daliresp/Daxas Trelegy Ellipta Trimbow Arnuity Ellipta Bevespi Aerosphere Lonhala Magnair Revefenacin PT010 Nucala RPL554 Fasenra Disease Indication Overview: This section of the report gives the overview of COPD disease indication in detail.
Hugh Windom of Windom Allergy, told me this was a one-year trial offering participants a 100 percent chance of getting either Spiriva or the nebulized version of Spiriva.